Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Already discounted as i see
No trades for two days in a row.
this is a guess. But, I feel there is accumulation and if I were the Malaysian, this is what I would do. They can get the remaining 43% for nothing
going private?
for sure i'm kidding. Since she's there, we went from 0,05 to less than 0,01
What do you want, Cynthia is doing a great job. Sorry, haven't seen the leading zero before the 9
Yes but usually management discussion is up to date including the latest development
the good point in this 10Q i: They still talk about a deal with Spectrum. The deal is not dead ... yet
it could be great if you identify youself. You post as the chairman. Is that right?
good news about Zevalin. A part of the regimen is Rituximab (RITUXAN). IMO, the deal is not dead
http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=695607
this news is very good for biosimilars in general.
http://www.bioportfolio.com/news/article/1086471/Trials-Of-Biosimilar-Monoclonal-Antibody-Prove-Biosimilarity.html
Not sure to understand. Are you telling me that you got in for some reasons and these reasons are not there anymore?
So johnstockstudent, what's up with your friend. Did he sell while you bought?
No trade today
maybe. But when I posted, it was not closed
the market is actually open in Germany. I don't understand what you mean
Again, the bid is much higher in Germany. Equivalent to 0,016
the free float is somewhere around 250M. Total outstanding is 900M
took in quarterly report of Spectrum:
In January 2011, we signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab. Biosimilars, or follow-on biologics, are terms used to describe officially-approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry. Under the agreement, we paid a nominal upfront payment and are required to make additional payments based on certain development, regulatory and sales milestones should we elect to continue development efforts.
don't forget to click "I agree"
try Vi5
when I posted, the bid was at 0,012 here. But now you're right! Same bid price
231k at 0,013€ on the bid at Frankfurt. Hum!
ya interesting. One block of 8600 at 0,029 then another 8600 at 0,013 5 minutes later. It closed at 0,013 euros
don't know why but there was trade of 0,029 euro in Frankfurt this afternoon
again. a small 1000 to bring back the price at 0,0148
I'm not saying it's okay. Either side, manipulation is manipulation. The question is Why? Why do they want you to think we stand at 0,016. Do they want to sell?
you always talk about manipulation on the sell side in order to maintain a low price. My reading is at the opposite, someon bought only 300 shares to bring back the price at 0,016. A mere 4,80$
you never talk about that guy who brought it back to 0,016 with only 300 shares
it's just a matter of being a serious company. And who knows if you won't learn something in these financials. If not, why if it so long.
without financials, you're sure right
So Johnstock? Any news from your european riend? More than two weeks that we're due for this news
0.0111 on the bid for you big news
See! It's not there anymore your big bid
On one side I hope you're right but on the other I don't think so. Let's see!
My point was about thé 500k bid
won't stay there
true bid? Why not buying at this level while it's still possible if they nkow something is coming?
you have a good question. The bid was at 0,15 before the opening. It disappeared and then got back after the opening. Someone wanted to print 0,009